Correlation Between Vanda Pharmaceuticals and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Viracta Therapeutics, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Viracta Therapeutics.
Diversification Opportunities for Vanda Pharmaceuticals and Viracta Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vanda and Viracta is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Vanda Pharmaceuticals and Viracta Therapeutics
Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 0.5 times more return on investment than Viracta Therapeutics. However, Vanda Pharmaceuticals is 1.98 times less risky than Viracta Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 456.00 in Vanda Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 63.00 from holding Vanda Pharmaceuticals or generate 13.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vanda Pharmaceuticals vs. Viracta Therapeutics
Performance |
| Timeline |
| Vanda Pharmaceuticals |
| Viracta Therapeutics |
Vanda Pharmaceuticals and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vanda Pharmaceuticals and Viracta Therapeutics
The main advantage of trading using opposite Vanda Pharmaceuticals and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Vanda Pharmaceuticals vs. Biomarin Pharmaceutical | Vanda Pharmaceuticals vs. Vaxcyte | Vanda Pharmaceuticals vs. Liquidia Technologies | Vanda Pharmaceuticals vs. Legend Biotech Corp |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |